Today: 7 February 2026
Subscribe
Browse Category

NYSE:CVS News 2 December 2025 - 28 December 2025

Healthcare Stocks Today: Weekend Headlines, 2026 Themes, and What to Watch Before Monday’s Open

Healthcare Stocks Today: Weekend Headlines, 2026 Themes, and What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 1:22 p.m. ET — Market closed (weekend). U.S. equity markets are shut for the weekend, but healthcare stocks are heading into Monday’s session with a fresh mix of catalysts—policy scrutiny around pharmacy practices, late-year sector rotation, and drug-development headlines—against a broader market backdrop that’s still flirting with major milestones. The S&P 500 has been within striking distance of 7,000, and strategists say the “path of least resistance” for stocks has remained higher absent a shock—an environment that can favor healthcare when investors look for diversification beyond the most crowded growth trades. Reuters Why healthcare stocks
28 December 2025
······
Shops Open on Christmas Day 2025 in the USA: Where You Can Still Buy Groceries, Medicine, and Last-Minute Essentials

Shops Open on Christmas Day 2025 in the USA: Where You Can Still Buy Groceries, Medicine, and Last-Minute Essentials

Updated: Thursday, Dec. 25, 2025 Christmas Day shopping in the United States is usually a “closed sign” kind of experience — but it’s not a total retail blackout. If you just realized you’re out of batteries, need a last-minute ingredient, forgot the medicine in your travel bag, or simply need coffee on the road, there are a few reliable options. Holiday-hours roundups published across major outlets on Dec. 24–25, 2025 show a consistent theme: big-box retailers and most supermarkets are closed, while pharmacies and convenience stores are your best bet.  NBC New York Below is a practical, nationwide guide to shops open on Christmas Day 2025 — plus
25 December 2025
··
CVS Stock After the Bell (Dec. 24, 2025): CVS Health Dips in After‑Hours Holiday Trade—Key News, Forecasts, and What to Watch Before the Next Open

CVS Stock After the Bell (Dec. 24, 2025): CVS Health Dips in After‑Hours Holiday Trade—Key News, Forecasts, and What to Watch Before the Next Open

CVS Health Corporation (NYSE: CVS) ended the Christmas Eve session higher, then eased modestly after hours as trading thinned into the holiday. CVS closed at $79.12, up 1.38%, in a shortened session that ended at 1:00 p.m. Eastern. In after-hours trading, the stock was $79.01 at 5:00 p.m. Eastern, down about 0.14% from the close. StockAnalysis Because U.S. markets are closed on Thursday, Dec. 25, 2025 (Christmas Day), the “next open” investors are preparing for is Friday, Dec. 26, 2025. New York Stock Exchange Below is what moved CVS into the close, the most relevant CVS-related headlines that hit on
25 December 2025
····
Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Updated: December 14, 2025Coverage window for this report: December 8–14, 2025 Wall Street heads into the week of Dec. 15, 2025 with U.S. healthcare and pharma mega-caps back in the spotlight—pulled by three powerful forces that all intensified in the last seven days: (1) the obesity-drug arms race, (2) Washington’s policy crosscurrents around insurance subsidies and PBM transparency, and (3) a faster-moving FDA that is simultaneously accelerating reviews and reopening safety scrutiny in sensitive pediatric categories. Reuters+3Reuters+3Reuters+3 The result is a “defensive sector” that doesn’t feel defensive at all right now. The Federal Reserve’s Dec. 9–10 meeting delivered another layer
14 December 2025
········
CVS Health Stock Surges on 2025–2026 Guidance: Key News, Forecasts and Analysis Since November 21, 2025

CVS Health Stock Surges on 2025–2026 Guidance: Key News, Forecasts and Analysis Since November 21, 2025

CVS Health Corporation (NYSE: CVS) has turned into one of 2025’s surprise winners in the healthcare sector. After a bruising 2023–2024 period of cost pressures and integration headaches, CVS stock has climbed roughly 70–80% year‑to‑date in 2025, making it one of the top performers in the S&P 500’s health-care names. Reuters+1 As of the latest close, CVS shares trade around $80.6 with a daily gain of about 2%, giving the company a market value just under $100 billion. Trefis For investors tracking CVS Health stock news specifically from November 21, 2025 onward, several developments stand out: Below is a structured,
11 December 2025
····
CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

CVS Health (CVS) Stock Soars in 2025 on New Guidance, AI Push and Clinic Reset – Is the Turnaround Finally Real?

New York / Hartford – December 10, 2025 – CVS Health Corporation (NYSE: CVS) is back in Wall Street’s good graces. After a bruising 2024, the stock has staged a powerful rebound in 2025 as management raised its 2025–2026 profit outlook, unveiled an AI‑native engagement platform, and tightened its primary‑care strategy. Shares were trading around $78 per share in midday trading on December 10, up roughly 2% on the day and around 75–80% year to date, far outpacing most large-cap healthcare peers. Reuters+2MarketWatch+2 With a market capitalization close to $100 billion, CVS has reasserted itself as one of the largest
10 December 2025
·····
CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Health Corp (NYSE: CVS) is back in the spotlight. As of December 6, 2025, CVS stock is trading around $75.60 per share, following a powerful 2025 rally but also a wave of fresh legal settlements, a major goodwill write‑down and renewed questions about its clinic strategy. At the same time, management has raised 2025 profit guidance, is signaling double‑digit earnings growth in 2026, and Wall Street now sees mid‑teens to low‑20% upside over the next 12 months. StockAnalysis+3Q4 Holdings+3Fierce Healthcare+3 Below is a detailed, news‑driven look at CVS: the latest developments as of December 6, 2025, plus forecasts, risks
6 December 2025
····
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

As of December 2, 2025, CVS Health Corporation (NYSE: CVS) finds itself in a classic “good news, bad headlines” moment: the stock has pulled back after a strong 2025 rally, the company agreed to a federal settlement over insulin-pen billing, and yet Wall Street’s forecasts still point to further upside. Below is a structured rundown of the latest price action, news, forecasts and analyses as of and since December 2, 2025. Share price on December 2, 2025: dip after a big year On Tuesday, December 2, 2025, CVS Health shares fell about 1.9%, closing at $77.62, even as the broader
3 December 2025
·····
CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

Data and news current as of December 1, 2025. This article is for informational purposes only and is not financial advice. CVS Health Stock Today: A Big 2025 Comeback, Slightly Off the Highs CVS Health Corporation (NYSE: CVS) has staged one of 2025’s quiet comeback stories. On December 1, 2025, CVS shares closed at $79.10, down about 1.6% on the day and snapping a three‑day winning streak, while the S&P 500 also slipped in a broadly weak session. The stock now sits roughly 7% below its 52‑week high of $85.15, set on October 29. MarketWatch+1 Over a longer horizon, the
2 December 2025
·····
1 2 3

Stock Market Today

OCBC share price ends lower ahead of Singapore banks’ earnings week — what investors watch next

OCBC share price ends lower ahead of Singapore banks’ earnings week — what investors watch next

7 February 2026
Singapore, Feb 7, 2026, 15:04 SGT — Market closed. Oversea-Chinese Banking Corporation Limited (OCBC) shares ended Friday down 1.03% at S$21.23. The stock traded between S$21.15 and S$21.35, with about 6.19 million shares changing hands. (Investing.com) With the Singapore market shut for the weekend, the focus shifts to the next catalyst rather than Friday’s tape. Investors want a clean read on whether pressure on bank lending spreads is finally easing as rates stabilise and funding costs cool. That matters now because results from Singapore’s three big lenders land in quick succession this month. Analysts have pointed to an end to
ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop